Butterfly® implant is deployed by means of a catheter (thin tube) through the vascular system onto the beating heart, thereby eliminating the need for open-heart surgery. The treatment can reduce costs due to shortened hospitalization times and may be available to non-option patients, along with younger, healthier patients.

The AVVie product has clear advantages over their competitors; a one-stage delivery, as opposed to a complicated multiple-stage delivery, and a physiological design, where the leaflets continue to function in a normal pattern post-implantation. Repair of the diseased valve takes less than 12 minutes.